Sfondo Header
L'angolo del dottorino
Contents
Search the site... Advanced search
✖

Congenital heart disease

Congenital heart diseases comprise structural abnormalities of the heart and great vessels that develop during prenatal life and alter, with widely varying severity, the path of blood flow, the workload of the cardiac chambers, or organ perfusion. Their presence from birth does not necessarily imply a neonatal diagnosis: some cause an emergency in the first hours of life, whereas others are recognized during childhood or only in adulthood. The term therefore identifies a developmental origin but does not, by itself, establish anatomical complexity, the need for intervention, or an individual's prognosis.

Epidemiological estimates depend on which defects are included, access to echocardiography, and the observation period. Major international reviews place the prevalence at birth at approximately 8–10 cases per 1,000 live births; in the meta-analysis by Liu and colleagues, the estimate for 2010–2017 was 9.41 per 1,000. These figures do not describe all populations uniformly and must not be confused with the frequency of isolated patent foramen ovale or of all mild valvular variants. Advances in prenatal diagnosis, surgery, and interventional cardiology have increased the adult population living with native, repaired, or palliated defects, making a lifelong perspective of care essential.

Understanding the various malformations requires linking anatomy and physiology. Two people with the same diagnostic label may have very different ventricular dimensions, pulmonary pressures, and histories of intervention; conversely, different anatomical abnormalities may share the same circulatory problem. The general overview of congenital heart disease addresses precisely this relationship between embryonic development, cardiac configuration, and circulatory adaptation after birth.

Origin, development, and mechanisms of disease

The heart develops through the integration of different cell populations, which must proliferate, migrate, and differentiate according to a coordinated spatial and temporal sequence. Chamber formation, separation of pulmonary and systemic pathways, valve development, and connection of the great vessels are not independent processes: an early disruption may affect several structures, whereas a later disturbance may produce a relatively localized lesion. This developmental continuity explains why a septal defect may be associated with a valvular or venous return anomaly, and why describing a single lesion does not complete the patient's assessment.

In some cases, a genetic cause can be identified, consisting of a chromosomal abnormality, a variation in the copy number of DNA segments, or a pathogenic variant in a gene involved in cardiac morphogenesis. Trisomy 21 is frequently associated with defects of the atrioventricular junction; the 22q11.2 deletion may be associated with conotruncal and aortic arch malformations; Williams–Beuren syndrome includes an arteriopathy related to elastin haploinsufficiency. The association between a syndrome and a phenotype guides investigations, but it does not justify considering every defect of that type to be genetically identical. Isolated forms, familial forms, and syndromic presentations with variable expressivity all occur.

Alongside established causes, maternal risk factors are recognized, including pregestational diabetes, certain teratogenic drug exposures, and specific infections during pregnancy. The causal significance is not equivalent for all epidemiological associations: an exposure may increase the probability of a malformation without allowing an individual case to be attributed to it. Proper assessment considers timing, dose, metabolic conditions, family characteristics, and possible concurrent factors. In most families, no single sufficient cause can be identified, and the absence of a molecular explanation does not mean that appropriate precautions were not taken during pregnancy.

The functional consequence of a malformation becomes clear when the route taken by blood is reconstructed. An abnormal connection between compartments may produce a shunt, meaning a transfer of blood that alters flow distribution; a narrowing increases the work required to propel blood past the obstruction; an abnormal connection may deliver poorly oxygenated blood into the systemic circulation or prevent effective separation of the two circuits. Defect size is only one variable: vascular resistance, ventricular compliance, and the possible presence of other obstructions also matter. A small, high-velocity defect may produce a prominent murmur, whereas a critical malformation may generate little audible sound on auscultation.

During fetal life, the placenta provides gas exchange, and the circulation uses physiological connections, including the foramen ovale and ductus arteriosus. With lung expansion and separation from the placenta, resistance changes in both circuits. A connection that is essential before birth should normally close or lose its significance; in some malformations, however, it remains temporarily necessary to maintain vital blood flow. Ductus arteriosus dependence helps explain why a newborn who is initially stable deteriorates when the ductus constricts. Likewise, pulmonary overcirculation from a large shunt may become apparent only after pulmonary vascular resistance falls over the following weeks.

Persistent abnormal loading induces adaptation of the cardiac chambers. Volume overload promotes dilatation and increased output; pressure overload requires greater wall tension and may cause hypertrophy. These mechanisms initially sustain circulation but become unfavorable when accompanied by fibrosis, valvular regurgitation, or reduced contractile reserve. Exposure of the pulmonary vessels to excessive flow and pressure may progressively alter arteriolar walls. Disease assessment must therefore distinguish the original defect from the consequences accumulated over time, because late anatomical repair does not necessarily reverse already established vascular or myocardial damage.

The main anatomical groups

Septal defects and shunts include communications at different levels of the circulation. In an atrial septal defect, predominantly left-to-right flow tends to overload the right heart; in a ventricular septal defect, significant flow reaches the pulmonary circulation and returns to the left-sided chambers, with effects that also depend on how restrictive the communication is. An atrioventricular septal defect involves the organization of the atrioventricular junction and its valves; it is not simply the sum of two septal holes. In patent ductus arteriosus, the communication between the aorta and pulmonary artery persists. These differences determine distinct clinical presentations, indications for closure, and corrective techniques.

Left heart obstructions may involve ventricular inflow, the outflow tract, the aortic valve, or the aortic arch. Coarctation of the aorta impedes the distribution of systemic blood flow, whereas congenital aortic stenosis increases left ventricular load. In hypoplastic left heart syndrome, the problem is more extensive and involves the inability of the left-sided structures to support the systemic circulation adequately. Distinguishing an isolated obstruction from insufficient ventricular development is crucial when choosing a biventricular pathway or a palliative strategy.

In right heart obstructions and anomalies, the limitation may affect blood flow toward the lungs, tricuspid valve function, or ventricular development. Mild congenital pulmonary stenosis may remain stable for a long time, whereas a critical form requires urgent neonatal assessment. Pulmonary atresia with intact ventricular septum also requires evaluation of coronary connections and their dependence on ventricular pressures. In Ebstein anomaly, abnormal tricuspid valve configuration and insertion jointly alter valvular competence, atrial volume, and the functional portion of the right ventricle.

Conotruncal heart defects primarily involve the outflow tracts and their connections to the great vessels. Tetralogy of Fallot combines a ventricular septal defect with outflow malalignment that contributes to pulmonary obstruction and an overriding aorta; right ventricular hypertrophy reflects the pressure load. In transposition of the great arteries, when the atrioventricular connections are concordant, the two circuits run in parallel, and survival depends on effective mixing of blood. Common arterial trunk and double-outlet right ventricle represent further configurations, whose physiology depends on blood flow distribution and the relationship between the ventricular septal defect and the arteries.

Venous return anomalies affect where blood from the lungs or systemic organs drains. In total anomalous pulmonary venous return, all pulmonary venous blood reaches the right side of the circulation; any obstruction to drainage can cause a severe respiratory and circulatory emergency. Partial forms may behave like a shunt and be recognized because of enlargement of the right-sided chambers. Vena caval variants, although sometimes well tolerated, become important during catheterization, device implantation, and surgery.

The functionally single-ventricle heart encompasses anatomies in which it is not possible, or not reasonably feasible, to support circulation with two separate, effective ventricles. Fontan circulation results from a surgical pathway that connects systemic venous return to the pulmonary arteries without an intervening subpulmonary ventricular pump. It provides functional separation of the blood pathways in selected patients, but introduces a distinctive physiology dependent on low pulmonary vascular resistance and an adequate venous pressure gradient. For this reason, surveillance must also encompass the liver, lymphatic system, renal function, and exercise capacity.

Congenital coronary anomalies alter the origin, course, or termination of the coronary arteries. Their clinical significance arises not merely from anatomical rarity but from the possibility of compromising myocardial perfusion. An origin from a different aortic sinus requires assessment of the proximal course and its relationship with the great vessels; origin from the pulmonary artery, as in ALCAPA, meaning anomalous origin of the left coronary artery from the pulmonary artery, produces a different hemodynamic mechanism. Congenital valvular anomalies, by contrast, involve leaflets, commissures, and the subvalvular apparatus, with possible combinations of stenosis and regurgitation.

The position of the heart and the arrangement of the organs represent a further level of analysis. Dextrocardia does not, by itself, indicate any particular intracardiac connection; in heterotaxy, anomalies of venous return, the atrioventricular junction, rhythm, and splenic function may coexist. Aortic arch anomalies and vascular rings may also present through compression of the trachea and esophagus, without cardiac symptoms necessarily predominating at first. In all these situations, the diagnostic objective is to reconstruct the entire cardiovascular architecture, avoiding deductions based solely on the heart's orientation or the name of the principal defect.

Clinical manifestations at different ages

Taking the clinical history changes according to the patient's age. During pregnancy, the starting point may be a suspected ultrasound abnormality or a familial risk factor; in the newborn, the course of the first hours of life, feeding effectiveness, respiratory rate, and any abnormal skin coloration are crucial. A report of an infant who frequently interrupts feeding, sweats, and breathes rapidly suggests increased cardiorespiratory work, but must be interpreted alongside growth, physical examination, and investigations. Apparently good health initially does not exclude a critical lesion, because a patent ductus arteriosus may temporarily maintain adequate perfusion.

Central cyanosis indicates reduced arterial oxygenation when it affects the mucous membranes and tongue; it is not the same as a purplish discoloration confined to cold extremities. In malformations that reduce pulmonary blood flow or impair mixing, it may appear early and be associated with irritability, drowsiness, or acidosis. In other conditions, shock predominates, with pallor, cold extremities, weak pulses, and reduced urine output. A murmur is not required to suspect either presentation. Severe systemic obstruction may present mainly as inadequate perfusion and initially be mistaken for sepsis.

During infancy, a shunt with pulmonary overcirculation may cause tachypnea, poor growth, and reduced feeding tolerance, whereas a less significant defect may be discovered because of a murmur detected during examination. In older children, behavior during play, comparison with peers, and interruptions of physical activity become informative. The family may describe a limitation as a sedentary disposition, particularly if it has always been present. Syncope during exertion, exercise-related chest pain, or sustained palpitations warrant targeted assessment, although they are not specific to congenital heart disease.

In adults, the history must reconstruct both the malformation and the interventions already performed. Repair during childhood may have left a regurgitant valve, a conduit prone to degeneration, an arrhythmogenic scar, or a ventricle subjected to nonphysiological loading. Dyspnea, reduced exercise capacity, edema, and palpitations may therefore indicate a late complication. The significance of a new arrhythmia depends on the context: loss of atrioventricular synchrony may be particularly poorly tolerated in Fontan circulation or an already impaired ventricle. Even an absence of symptoms requires caution when the patient has progressively reduced their activities.

After history taking, the physical examination proceeds from general assessment to cardiovascular examination. Growth, nutritional status, work of breathing, coloration, and any relevant dysmorphic features are assessed; heart rate, blood pressure, and peripheral oxygen saturation are measured. In newborns, and whenever indicated, preductal and postductal saturations are compared. Palpation of femoral pulses and comparison of blood pressure between the upper and lower limbs help identify a possible aortic obstruction. Precordial palpation, cardiac auscultation, and characterization of murmurs complete the assessment, along with examination for hepatomegaly and signs of venous congestion.

A discrepancy between symptoms and the presumed anatomy is an important diagnostic clue. Deterioration should not automatically be attributed to the known defect: infections, anemia, respiratory disease, pregnancy, hypertension, or acquired heart disease may alter tolerance of the lesion. At the same time, an apparently reassuring oxygen saturation does not guarantee adequate systemic blood flow, particularly in circulations with mixing. Clinical interpretation therefore requires relating each finding to oxygenation, cardiac output, and congestion, while keeping the differential diagnosis open until imaging and other investigations clarify the predominant mechanism.

Investigations and the diagnostic pathway

The diagnostic pathway begins with a specific clinical question: to identify a suspected malformation, explain a symptom, quantify a hemodynamic consequence, or monitor progression after an intervention. Echocardiography is normally the first anatomical and functional investigation. The analysis must define situs, venous return, atrioventricular and ventriculoarterial connections, septa, valves, outflow tracts, and the aortic arch. Color Doppler and spectral Doppler provide additional information on flow direction, velocity, gradients, and regurgitation. The examination does not end with visualizing the defect: it must demonstrate its effects on the cardiac chambers and look for associated abnormalities.

In prenatal care, obstetric screening and fetal echocardiography play complementary roles. A suspected abnormality or risk condition may prompt referral to a fetal cardiologist; the specialist examination defines anatomy, function, and rhythm, allowing care and the place of delivery to be planned. Results must be communicated together with the limitations of the method: some small defects may not be identified, and certain obstructions change during gestation or become apparent after birth. Prenatal diagnosis is particularly useful when it anticipates the need to keep a vital communication open or perform an urgent procedure after delivery.

In newborns, pulse oximetry screening improves the detection of some critical congenital heart defects associated with hypoxemia, but does not replace clinical examination and does not exclude all left heart obstructions. The result must be interpreted according to the applicable protocol, taking signal quality and the infant's condition into account. A symptomatic newborn requires immediate clinical assessment regardless of the screening result. Electrocardiography and chest radiography may provide preliminary diagnostic information, whereas blood gas analysis, lactate, and other tests evaluate systemic consequences in unstable patients.

When echocardiography does not answer every question, cardiac magnetic resonance imaging allows anatomical reconstruction and reproducible quantification of ventricular volumes and flows. It is particularly useful for the right ventricle, pulmonary arteries, shunts, and follow-up of many surgically treated anatomies. Computed tomography provides high spatial resolution and rapid assessment of the coronary arteries, aorta, airways, and extracardiac relationships. Choosing between the two methods depends on the clinical question, age, ability to cooperate, presence of devices, and need to limit radiation and sedation. Not every patient needs to undergo all imaging modalities.

Cardiac catheterization retains an essential role when direct measurements of pressures, saturations, and resistances are needed or when percutaneous treatment is planned. When pulmonary vascular disease is suspected, echocardiography may suggest a problem but does not always replace the hemodynamic study needed for therapeutic decisions. Quantification of a shunt must also be consistent with the anatomy and chamber dimensions. The ratio of pulmonary to systemic blood flow, pulmonary vascular resistance, and filling pressures answer different questions and are not interchangeable measurements.

There is no single set of diagnostic criteria applicable to all congenital heart diseases. Establishing a definitive diagnosis requires demonstrating the anomaly with an appropriate method, describing its connections, and determining its functional consequences according to the recommendations relevant to the particular lesion. Genetic assessment complements the pathway when the phenotype, family history, or extracardiac anomalies make it useful; a molecular test may identify an etiology, but does not replace the cardiological description. During follow-up, rhythm monitoring, cardiopulmonary exercise testing, and assessment of target organs enable recognition of changes that a single anatomical image could not capture.

Principles of treatment and prognosis

Treatment is selected by integrating anatomy, physiology, age, and technical options. Some lesions require monitoring alone, others planned correction, and still others urgent stabilization followed by intervention. Contemporary guidelines emphasize assessment at centers experienced in congenital heart disease, particularly for complex cases and adults who need cardiac or noncardiac procedures. The decision is not simply whether a malformation is operable: it is necessary to assess which intervention will improve circulation, at what time, and with what future consequences.

In a newborn with suspected ductus-dependent circulation, stabilization may require prostaglandin E1 to maintain or restore ductal patency, together with intensive monitoring and respiratory and circulatory support. Treatment is guided by physiology: excessive blood flow to the lungs may divert blood away from the systemic circulation in certain anatomies. In transposition with inadequate mixing, urgent atrial septostomy may be necessary; in obstructed pulmonary venous return, the obstruction must be relieved. These examples show why treatment should follow reconstruction of the circulatory circuit rather than apply the same response to every episode of oxygen desaturation.

Interventional cardiology makes it possible, in selected anatomies, to close communications, dilate valves, treat vascular stenoses, and implant devices or prostheses. Surgery remains necessary when connections must be reconstructed, multiple components corrected, or structures unsuitable for percutaneous treatment addressed. For shunt lesions, the presence of an opening does not by itself indicate closure: overload, symptoms, pulmonary pressure, and ventricular conditions must be considered. A communication that permits decompression of a severely hypertensive circuit may be dangerous to eliminate. The choice of technique must also take account of the risk of repeat interventions and preservation of subsequent therapeutic options.

In anatomies that cannot undergo biventricular separation, palliation changes the route of blood flow to achieve a sustainable circulation. It does not mean the absence of active treatment: it may involve several interventions and an extended program of specialist care. Fontan circulation is one example, with goals including reducing cyanosis, limiting ventricular overload, and maintaining blood flow. Drug treatment addresses specific problems, such as congestion, arrhythmias, thrombosis, or pulmonary arterial hypertension, but does not eliminate an abnormal anatomical connection. The efficacy of a drug established in acquired left ventricular heart failure should not automatically be ascribed to every congenital systemic ventricle.

Care continues with prevention and surveillance. This includes oral hygiene, assessment of indications for endocarditis prophylaxis, management of acquired cardiovascular risk factors, physical activity appropriate to the risk, and developmental support. Antibiotic prophylaxis is not uniformly necessary for all malformations: it applies to selected conditions and procedures. Pregnancy requires specific preconception assessment, because risk depends on ventricular function, pulmonary pressure, the aorta, cyanosis, and other characteristics. A history of repair is not sufficient to classify pregnancy automatically as safe or contraindicated.

Prognosis is highly heterogeneous. A simple defect treated before irreversible damage develops, with no significant sequelae, may allow a long life with good functional capacity; complex conditions instead require ongoing follow-up and potentially repeated procedures. The technical success of intervention, myocardial reserve, pulmonary vasculature, comorbidities, and continuity of care all contribute to the course. Prognostic assessment must be updated over time: a clinically stable patient may move into another risk category following an arrhythmia, ventricular dysfunction, or extracardiac complication. The transition from pediatric to adult care is therefore a substantive part of treatment.

Complications and long-term surveillance

Complications do not occur with uniform frequency across the population: they depend on the defect, duration of hemodynamic exposure, and previous interventions. Among the most important problems in adult practice are arrhythmias and heart failure. Atrial dilatation, surgical scars, and electrical remodeling may promote reentrant circuits; pressure or volume loading, valvular dysfunction, and ischemia may progressively impair ventricular function. Tachycardia may be both a consequence and a cause of hemodynamic deterioration. The emergence of new symptoms therefore requires assessment of rhythm, residual anatomy, and cardiac function together.

Pulmonary arterial hypertension is a major complication of certain shunts and may persist or develop even after their repair. When vascular disease markedly increases pulmonary vascular resistance, flow through the communication may become bidirectional or reverse, producing Eisenmenger syndrome. In this condition, the problem is no longer merely the septal defect: it is a cardiopulmonary and systemic disease in which inappropriate closure may compromise circulatory balance. Even a defect in which the shunt appears to decrease over time requires attention if this change results from increasing resistance.

Chronic cyanosis triggers a compensatory increase in red cell mass and alters hemostasis. Thrombotic risk and bleeding tendency may coexist, while dehydration and iron deficiency may worsen symptoms and oxygen transport. Secondary erythrocytosis must not be equated with a myeloproliferative disorder and does not justify automatic phlebotomy based on hematocrit alone. A right-to-left shunt may allow emboli or infected material to enter the systemic circulation, contributing to neurological complications. Management requires specific expertise and attention to conditions that may disturb an already delicate compensatory balance.

Infective endocarditis may develop on vulnerable endocardial surfaces, valves, or prosthetic material. Risk varies according to the underlying substrate and the interventions performed; persistent fever, bacteremia, or new valvular findings warrant appropriate assessment. Prostheses and conduits may also undergo degeneration, stenosis, or regurgitation independently of infection. Hypertension and vascular abnormalities may persist after aortic arch repair; in aortopathies, progressive dilatation requires reproducible measurements. Postoperative follow-up must therefore take account of what was reconstructed, which materials were used, and which structures remain exposed to abnormal loads.

In Fontan circulation, chronically elevated venous pressure and limited ability to increase cardiac output may affect numerous organs. Hepatic congestion promotes fibrosis; altered lymphatic dynamics may contribute to protein-losing enteropathy and plastic bronchitis. A preserved ejection fraction does not exclude failure of this circulation, because the main limitation may involve filling, the pulmonary circuit, or the venous system. Surveillance must therefore extend beyond the assessment of systolic function alone.

The consequences of the disease also involve neurodevelopment, learning, psychological health, and social participation. In at-risk children, neurological vulnerability may precede the intervention and be influenced by genetic factors, fetal perfusion, perioperative conditions, and the family environment. A school-related or behavioral difficulty should not automatically be attributed to a single surgical event and merits timely assessment and support. In adults, recognizing warning signs, retaining medical documentation, and attending follow-up appointments help prevent interruptions in care. Quality of care is thus also measured by the opportunity to grow, study, work, and plan one's life with information proportionate to the actual risk.

References
  1. Gurvitz M et al. 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2026;87(7):822-976.
  2. Baumgartner H et al. 2020 ESC Guidelines for the management of adult congenital heart disease. European Heart Journal. 2021;42(6):563-645.
  3. Liu Y et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. International Journal of Epidemiology. 2019;48(2):455-463.
  4. van der Linde D et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. Journal of the American College of Cardiology. 2011;58(21):2241-2247.
  5. Pierpont ME et al. Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association. Circulation. 2018;138(21):e653-e711.
  6. Zaidi S et al. Genetics and Genomics of Congenital Heart Disease. Circulation Research. 2017;120(6):923-940.
  7. Jenkins KJ et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115(23):2995-3014.
  8. Moon-Grady AJ et al. Guidelines and Recommendations for Performance of the Fetal Echocardiogram: An Update from the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2023;36(7):679-723.
  9. Donofrio MT et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129(21):2183-2242.
  10. Fratz S et al. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. Journal of Cardiovascular Magnetic Resonance. 2013;15(1):51.
  11. Humbert M et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal. 2022;43(38):3618-3731.
  12. Rychik J et al. Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association. Circulation. 2019;140(6):e234-e284.
  13. De Backer J et al. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. European Heart Journal. 2025;46(43):4462-4568.
  14. Delgado V et al. 2023 ESC Guidelines for the management of endocarditis. European Heart Journal. 2023;44(39):3948-4042.
  15. Sood E et al. Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association. Circulation. 2024;149(13):e997-e1022.
  16. Diller GP et al. Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre. Circulation. 2015;132(22):2118-2125.
  17. Hernández-Madrid A et al. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital Heart Disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace. 2018;20(11):1719-1753.
  18. Khalil M et al. Acute therapy of newborns with critical congenital heart disease. Translational Pediatrics. 2019;8(2):114-126.
  19. Anderson RH et al. Development of the heart: (2) Septation of the atriums and ventricles. Heart. 2003;89(8):949-958.
  20. Gewillig M et al. The Fontan circulation after 45 years: update in physiology. Heart. 2016;102(14):1081-1086.
  21. Abouk R et al. Association of US State Implementation of Newborn Screening Policies for Critical Congenital Heart Disease With Early Infant Cardiac Deaths. JAMA. 2017;318(21):2111-2118.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.